Regencell Bioscience Holdings Limited
RGC Healthcare
₹ 25.4
5.18%
Live Market Data
Market Cap₹ 1,256 Cr.
Current Price₹ 25.4
High / Low₹83.6 / 0.552632
Stock P/E0.0
Book Value₹0.0
Dividend Yield0.00 %
ROCE-0.3 %
ROE-0.5 %
About Company
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Industry Segment
Drug Manufacturers - Specialty & Generic
Price Chart
Loading Chart...
Technical Analysis
Technical Outlook
Short TermBearish
Mid TermBullish
Long TermNeutral
Resistance₹28.96
Support₹0.14816
Valuation Check
Fair Value Assessment
Overvalued
Research Reports
Daily – Vickers Top Buyers & Sellers for 01/15/2026
Raising target price to $32.00
Quarterly Results
| Particulars | Jan 70 | Jan 70 |
|---|---|---|
| Total Revenue (Cr) | 0 | 0 |
| Net Income (Cr) | 0 | 0 |
| EPS (₹) | 0 | 0 |
Annual Profit & Loss
| Particulars | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Total Revenue (Cr) | 0 | 0 | 0 | 0 |
| Operating Exp (Cr) | 0.47 | 0.63 | 0.76 | 0.14 |
| Net Income (Cr) | -0.43 | -0.59 | -0.74 | -0.13 |
| EPS (₹) | -0.01 | -0.01 | -0.02 | -0 |
Balance Sheet
| Particulars | Jan 70 | Jan 70 |
|---|---|---|
| Total Assets (Cr) | 0.75 | 0.84 |
| Total Liabilities (Cr) | 0.08 | 0.02 |
| Total Equity (Cr) | 0.67 | 0.82 |
Key Ratios Fundamentals
Valuation
P/E Ratio (TTM)
-Forward P/E
-PEG Ratio
-Price / Book
2540.00EV / EBITDA
-3233.10Profitability
ROE
-54.81%ROA
-33.20%Profit Margin
-Operating Margin
-Liquidity & Debt
Current Ratio
7.39Quick Ratio
7.38Debt / Equity
11.20Total Cash (Cr)
0.49Price Statistics
Beta
2.0752W High
83.6052W Low
0.55Dividend Yield
-Pattern Unavailable
Detailed shareholding breakdown is not currently provided by the exchange.